EUVIMEDEUVIMED entdecken
Open Access

Multifunctional Lipid Nanoparticles Remodeling Tumor Immune Microenvironment for Breast Cancer Chemo-Immunotherapy

Wei Jiang, You Zheng, Zhouhong Jing, Xiangling Yu, Huiying Fang

Oncology Research · 2026 · 34 (6) · 1-10

DOI: 10.32604/or.2026.078278 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Wei Jiang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, Chongqing, China. Hauptthemen laut MEDLINE: Tumor Microenvironment, Breast Neoplasms, Nanoparticles. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Breast cancer treatment is often hampered by the immunosuppressive tumor microenvironment (TME). To improve therapeutic efficacy, this study developed a folic acid-chitosan (FA-CS)-modified liposomal formulation co-delivering doxorubicin (DOX) and resiquimod (R848) for combined chemotherapy and immune modulation.

Methods

The FA-CS-R848/DOX@Lip liposomes were prepared by rotary evaporation and characterized for morphology, particle size, zeta potential, drug encapsulation efficiency (EE), drug loading (DL) capacity, and drug release profiles. Cellular uptake and cytotoxicity were determined to assess the biological effects of the formulation. Antitumor efficacy and biosafety were assessed in an EO771 tumor-bearing mouse model. The macrophage phenotype, TME composition, and CD8+ T cell cytotoxic function were evaluated by flow cytometry.

Results

The FA-CS-R848/DOX@Lip exhibited a relatively uniform spherical morphology, with an average size of 221.53 nm and a zeta potential of 5.06 mV. The EE (%) of R848 and DOX were over 70% and 80%, respectively, while the DL (%) capacities were 4.6% and 3.1%. Drug release studies showed a slow release profile. In vitro, FA-CS-R848/DOX@Lip showed greater cytotoxicity than non-targeted liposomes (p 0.05). In addition, FA-CS-R848/DOX@Lip increased the MHC II/CD206 ratio of tumor-associated macrophages (TAMs), elevated the proportions of CD8+ and CD4+ T cells, reduced the proportion of myeloid-derived suppressor cells (MDSCs), and enhanced the percentages of IFNγ+ and Ki67+ CD8+ T cells in vivo.

Conclusions

FA-CS-R848/DOX@Lip exerts potent antitumor activity with favorable biosafety in vivo. Its therapeutic effect may be associated with improved immune activation and remodeling of the TME, supporting its potential as a chemo-immunotherapeutic strategy for breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor MicroenvironmentBreast NeoplasmsNanoparticlesAnimalsFemaleMiceDoxorubicinImidazolesHumansLiposomesImmunotherapyChitosanCell Line, TumorLipidsFolic Acid

Stichwörter der Autor:innen

Breast cancerchemotherapydoxorubicindrug deliveryimmunotherapyliposomesresiquimod

Substanzen

DoxorubicinresiquimodImidazolesLiposomesChitosanLipidsFolic AcidLipid Nanoparticles

Autor:innen und Institutionen

  • Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, No. 74 Linjiang Rd, Yuzhong District, Chongqing, China.
  • Department of Breast Cancer Center, Chongqing Key Laboratory for Intelligent Oncology in Breast Cancer (iCQBC), Chongqing University Cancer Hospital, No. 181 Hanyu Rd, Shapingba District, Chongqing, China.

Zitieren

APA

Jiang, W., Zheng, Y., Jing, Z., Yu, X., & Fang, H. (2026). Multifunctional Lipid Nanoparticles Remodeling Tumor Immune Microenvironment for Breast Cancer Chemo-Immunotherapy. Oncology Research, 34(6), 1-10. https://doi.org/10.32604/or.2026.078278

Vancouver

Jiang W, Zheng Y, Jing Z, Yu X, Fang H. Multifunctional Lipid Nanoparticles Remodeling Tumor Immune Microenvironment for Breast Cancer Chemo-Immunotherapy. Oncology Research. 2026;34(6):1-10. doi:10.32604/or.2026.078278

BibTeX
@article{Jiang2026,
  author = {Jiang, Wei and Zheng, You and Jing, Zhouhong and Yu, Xiangling and Fang, Huiying},
  title = {Multifunctional Lipid Nanoparticles Remodeling Tumor Immune Microenvironment for Breast Cancer Chemo-Immunotherapy},
  journal = {Oncology Research},
  year = {2026},
  volume = {34},
  number = {6},
  pages = {1--10},
  doi = {10.32604/or.2026.078278}
}
Kostenlos starten →